Abstract 339: Neuroendovascular Headache Management ‐ Leveraging the Middle Meningeal Artery as an Effective Conduit
Migraines are the 3rd most common disease in the world. The trigeminovascular system's role in migraine's pathophysiology provides a rational for using Intraarterial (IA) blockade of the trigeminal ganglion for migraine treatment. Recent studies, has highlighted middle meningeal artery (MMA) as an effective pathway for IA therapy in the treatment of refractory headaches. We report the result of IA injection of medications into the MMA in a patient with refractory migraines.
Authors
- Chirag D. Gandhi (ORCID: https://orcid.org/0000-0002-8423-0414)
- Fawaz Al‐Mufti (ORCID: https://orcid.org/0000-0003-4461-7005)
- I. Moeini Naghani
- Mohamed Elfil (ORCID: https://orcid.org/0000-0002-1125-2946)
- Jianping Li (ORCID: https://orcid.org/0000-0002-8526-1095)
- A. Elmashad
Institutions
- Westchester Medical Center (US)
- University of Miami (US)
- Jackson Health System (US)
Publication Details
- Journal
- Stroke Vascular and Interventional Neurology
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1161/svin.04.suppl_1.339
- Primary Topic
- Cerebral Venous Sinus Thrombosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00